Pancreatic Cancer Research

ResearcherUniversity of BernActive in the last 2 years

Andréas Andreou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0040-8463; OpenAlex author ID A5103011127. Sources: OpenAlex.

Their work

Papers
8 (first author 2, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
16
Papers, trials and grants by year

2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 2 papers · 2026: 1 paper

Papers 8

  1. ASO Visual Abstract: Initiation and Completion of Adjuvant Chemotherapy After Total versus Partial Pancreaticoduodenectomy for Pancreatic Cancer. Co-author DOI 10.1245/s10434-025-18579-w↗
  2. Initiation and Completion of Adjuvant Chemotherapy After Total Versus Partial Pancreaticoduodenectomy for Pancreatic Cancer. Co-author DOI 10.1245/s10434-025-18378-3↗
  3. Impact of Routine and Selective Preoperative Endoscopic Retrograde Cholangiopancreatography with Stent Placement on Postoperative and Oncologic Outcomes Follow… Last author DOI 10.3390/biomedicines13020333↗
  4. Resection margin status at the portomesenteric axis may not determine oncologic outcome after pancreaticoduodenectomy for lymph node-positive pancreatic ductal… Last author DOI 10.1016/j.surg.2023.03.007↗
  5. High tumor mutational burden (TMB) identifies a microsatellite stable pancreatic cancer subset with prolonged survival and strong anti-tumor immunity. First author DOI 10.1016/j.ejca.2022.03.033↗
  6. PD-1/PD-L1-Associated Immunoarchitectural Patterns Stratify Pancreatic Cancer Patients into Prognostic/Predictive Subgroups. First author DOI 10.1158/2326-6066.cir-21-0144↗
  7. The role of hepatectomy for synchronous liver metastases from pancreatic adenocarcinoma. Co-author DOI 10.1016/j.suronc.2018.09.004↗
  8. Incidence and Oncological Implications of Previously Undetected Tumor Multicentricity Following Pancreaticoduodenectomy for Pancreatic Adenocarcinoma in Patien… Co-author DOI 10.21873/anticanres.11952↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Beat Gloor · 6 shared papers, 2021–2026 · strength 1.32
  2. Anna Silvia Wenning · 5 shared papers, 2022–2026 · strength 1.16
  3. Pauline Aeschbacher · 4 shared papers, 2023–2026 · strength 0.96
  4. Romy Weber · 2 shared papers, 2025–2026 · strength 0.53
  5. Martin D. Berger · 2 shared papers, 2025–2026 · strength 0.53
  6. Benjamin Struecker · 3 shared papers, 2018–2025 · strength 0.49
  7. Shadi Katou · 2 shared papers, 2023–2025 · strength 0.42
  8. Aurel A. Perren · 2 shared papers, 2021–2022 · strength 0.36
  9. Eva Karamitopoulou · 2 shared papers, 2021–2022 · strength 0.36
  10. Marcus Bahra · 2 shared papers, 2017–2018 · strength 0.14
  11. Fritz Klein · 2 shared papers, 2017–2018 · strength 0.14
  12. Rosa Bianca Schmuck · 2 shared papers, 2017–2018 · strength 0.14
  13. Timm Denecke · 2 shared papers, 2017–2018 · strength 0.14
  14. Marianne Sinn · 1 shared paper, 2017 · strength 0.07
  15. Thomas Malinka · 1 shared paper, 2018 · strength 0.07
  16. Uwe Pelzer · 1 shared paper, 2018 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.